Literature DB >> 21146985

Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivatives.

Romeo Romagnoli1, Pier Giovanni Baraldi, Olga Cruz-Lopez, Manlio Tolomeo, Antonietta Di Cristina, Rosaria Maria Pipitone, Stefania Grimaudo, Jan Balzarini, Andrea Brancale, Ernest Hamel.   

Abstract

Microtubules are dynamic structures that play a crucial role in cellular division and are recognized as an important target for cancer therapy. In search of new compounds with strong antiproliferative activity and simple molecular structure, a new series of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-(hetero)aryl ethynyl thiophene derivatives was prepared by the Sonogashira coupling reaction of the corresponding 5-bromothiophenes with several (hetero)aryl acetylenes. When these compounds were analyzed in vitro for their inhibition of cell proliferation, the 2- and 3-thiophenyl acetylene derivatives were the most powerful compounds, both of which exerted cytostatic effects at submicromolar concentrations. In contrast, the presence of a more flexible ethyl chain between the (hetero)aryl and the 5-position of the thiophene ring resulted in significant reduction in activity relative to the 5-(hetero)aryl acetylene substituted derivatives. The effects of a selected series of compounds on cell cycle progression correlated well with their strong antiproliferative activity and inhibition of tubulin polymerization. We found that the antiproliferative effects of the most active compounds were associated with increase of the proportion of cells in the G(2)/M and sub-G(1) phases of the cell cycle.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146985      PMCID: PMC3102432          DOI: 10.1016/j.bmcl.2010.11.083

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  22 in total

1.  Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents.

Authors:  Jing-Ping Liou; Chun-Wei Chang; Jeng-Shin Song; Yung-Ning Yang; Ching-Fang Yeh; Huan-Yi Tseng; Yu-Kang Lo; Yi-Ling Chang; Chung-Ming Chang; Hsing-Pang Hsieh
Journal:  J Med Chem       Date:  2002-06-06       Impact factor: 7.446

2.  Microtubule structure and its stabilisation.

Authors:  Linda A Amos
Journal:  Org Biomol Chem       Date:  2004-07-14       Impact factor: 3.876

Review 3.  Microtubules as a target for anticancer drugs.

Authors:  Mary Ann Jordan; Leslie Wilson
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

4.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

Review 5.  Update on tubulin-binding agents.

Authors:  Gerhardt Attard; Alastair Greystoke; Stan Kaye; Johann De Bono
Journal:  Pathol Biol (Paris)       Date:  2006-03

6.  Antineoplastic agents. 379. Synthesis of phenstatin phosphate.

Authors:  G R Pettit; B Toki; D L Herald; P Verdier-Pinard; M R Boyd; E Hamel; R K Pettit
Journal:  J Med Chem       Date:  1998-05-07       Impact factor: 7.446

7.  Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.

Authors:  P Verdier-Pinard; J Y Lai; H D Yoo; J Yu; B Marquez; D G Nagle; M Nambu; J D White; J R Falck; W H Gerwick; B W Day; E Hamel
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

Review 8.  Understanding microtubule dynamics for improved cancer therapy.

Authors:  S Honore; E Pasquier; D Braguer
Journal:  Cell Mol Life Sci       Date:  2005-12       Impact factor: 9.261

Review 9.  Combretastatin a-4 analogs as anticancer agents.

Authors:  Anurag Chaudhary; S N Pandeya; P Kumar; P P Sharma; S Gupta; N Soni; K K Verma; G Bhardwaj
Journal:  Mini Rev Med Chem       Date:  2007-12       Impact factor: 3.862

10.  Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Taradas Sarkar; Maria Dora Carrion; Carlota Lopez Cara; Olga Cruz-Lopez; Delia Preti; Mojgan Aghazadeh Tabrizi; Manlio Tolomeo; Stefania Grimaudo; Antonella Di Cristina; Nicola Zonta; Jan Balzarini; Andrea Brancale; Hsing-Pang Hsieh; Ernest Hamel
Journal:  J Med Chem       Date:  2008-02-09       Impact factor: 7.446

View more
  1 in total

1.  N'-[(1E)-(5-Nitro-furan-2-yl)methyl-idene]thio-phene-2-carbohydrazide: crystal structure and Hirshfeld surface analysis.

Authors:  Laura N F Cardoso; Thais C M Nogueira; James L Wardell; Solange M S V Wardell; Marcus V N de Souza; Mukesh M Jotani; Edward R T Tiekink
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.